產(chǎn)品名稱 MLN-9708 from BIOVISION, INC.
    產(chǎn)品貨號 B2195-5
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
    產(chǎn)品規(guī)格 5 mg
    產(chǎn)品品牌 BIOVISION, INC.
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameMLN-9708
    DescriptionMLN-9708 is a prodrug of Ixazomib citrate (MLN-2238). MLN-9708 is an orally bioavailable next-generation proteasome inhibitor (PI) with potential potent anticancer activity in both hematologic and solid tumor xenograft models with better pharmacokinetic and pharmacodynamic features than PS-341 (Cat. No. 1846). MW: 517.12. Purity ≥98% by HPLC
    Size5 mg
    Concentrationn/a
    Applicationsn/a
    Other Names4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid; ixazomib
    Gene, Accession, CAS #CAS: 1239908-20-3
    Catalog #B2195-5
    Price
    Order / More InfoMLN-9708 from BIOVISION, INC.
    Product Specific Referencesn/a
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>